Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study – il AD (Italian landscape atopic dermatitis).
Saved in:
| Title: | Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study – il AD (Italian landscape atopic dermatitis). |
|---|---|
| Authors: | Gargiulo, Luigi1,2 (AUTHOR), Ibba, Luciano1,2 (AUTHOR), Alfano, Angela1,2 (AUTHOR), Malagoli, Piergiorgio3 (AUTHOR), Amoruso, Fabrizio4 (AUTHOR), Balato, Anna5 (AUTHOR), Barei, Francesca6 (AUTHOR), Burroni, Anna G.7 (AUTHOR), Caccavale, Stefano5 (AUTHOR), Calzavara-Pinton, Piergiacomo8 (AUTHOR), Esposito, Maria9 (AUTHOR), Fargnoli, Maria C.9 (AUTHOR), Ferrucci, Silvia M.6 (AUTHOR), Foti, Caterina10 (AUTHOR), Girolomoni, Giampiero11 (AUTHOR), Gola, Massimo12 (AUTHOR), Guanti, Mario B.13 (AUTHOR), Gurioli, Carlotta14,15 (AUTHOR), Magliulo, Manfredi12 (AUTHOR), Maurelli, Martina11 (AUTHOR) |
| Source: | Journal of Dermatological Treatment. Dec2024, Vol. 35 Issue 1, p1-5. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
